Red X iconGreen tick iconYellow tick icon

Miriam Rademaker Research Associate Professor

BSc(Cant) PhD(Otago)

Email miriam.rademaker@otago.ac.nz

Department of Medicine
University of Otago, Christchurch
PO Box 4345
Christchurch
New Zealand

Current roles

  • Research Associate Professor, Department of Medicine
  • Co-Director, Physiology Division, Christchurch Heart Institute
  • Principle Investigator of physiological based studies
  • Member of Faculty of the Christchurch School of Medicine
  • Member of The Canterbury Medical Research Society
  • Editorial Board, American Journal of Physiology: Reg., Int.
  • Editorial Board, Clinical Science

Research interests

Research focus is on the integrated cardiovascular, endocrine and renal control of pressure/volume homeostasis.

Particular emphasis is placed on the role that key vasoactive hormones (such as the natriuretic peptides, adrenomedullins, endothelin and the renin-angiotensin-aldosterone system) play in the pathophysiology of circulatory diseases such as hypertension, myocardial infarction and heart failure, and ways of manipulating these systems in order to prevent and treat these diseases.

Over the past decade interest has widened to include the novel urocortin family of peptides, phosphodiesterase 9 inhibition and natriuretic peptide analogues engineered to have distinct vasodilatory or renal activity, as well as renal dysfunction in heart failure (one of the most important risk factors for morbidity and mortality in this disease) and novel implantable devices that may potentially be used to identify early decompensation in heart failure and to optimise anti-failure treatment.

Publications

Rademaker, M. T., Scott, N. J. A., Charles, C. J., & Richards, A. M. (2024). Combined inhibition of phosphodiesterases-5 and -9 in experimental heart failure. JACC: Heart Failure, 12(1), 100-113. doi: 10.1016/j.jchf.2023.08.028

Wong, L. L., Fadzil, A. B., Chen, Q., Rademaker, M. T., Charles, C. J., Richards, A. M., & Wang, P. (2023). Interrogating the role of miR-125b and its 3’isomiRs in protection against hypoxia. International Journal of Molecular Sciences, 24, 16015. doi: 10.3390/ijms242116015

Templeton, E. M., Pilbrow, A. P., Kleffmann, T., Pickering, J. W., Rademaker, M. T., Scott, N. J. A., Ellmers, L. J., Charles, C. J., Endre, Z. H., Richards, A. M., Cameron, V. A., & Lassé, M. (2023). Comparison of SPEED, S-Trap, and in-solution-based sample preparation methods for mass spectrometry in kidney tissue and plasma. International Journal of Molecular Sciences, 24(7), 6290. doi: 10.3390/ijms24076290

Scott, N. J. A., Prickett, T. C. R., Charles, C. J., Frampton, C. M., Richards, A. M., & Rademaker, M. T. (2023). Augmentation of natriuretic peptide bioactivity via combined inhibition of neprilysin and phosphodiesterase-9 in heart failure. JACC: Heart Failure, 11(2), 227-239. doi: 10.1016/j.jchf.2022.11.006

Templeton, E., Lassé, M., Cameron, V., Pickering, J., Kleffmann, T., Hertzberg, D., Frampton, C., Ellmers, L., Palmer, S., … Scott, N., Charles, C., … Richards, M., … Troughton, R., Rademaker, M., & Pilbrow, A. (2022). Harnessing the power of 'Omics': Discovering novel microRNA and protein biomarkers of acute kidney injury in acute heart failure. Heart, Lung & Circulation, 31(Suppl. 2), (pp. S23-S24). doi: 10.1016/j.hlc.2022.05.009

Back to top